glp-1-based therapy Better results, starting now: your nutrition roadmap for GLP-1 Oral GLP-1-Based Therapeutics in the

There was a connection between age, BMI, waist circumference, and exercise intensity

Programmed cell death in diabetic nephropathy: a review of apoptosis, autophagy, and necroptosis

More than 4,400 cases were consolidated in federal court as of January 2026

Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)

The question is no longer just a simple yes or no